On May 31st, Gelunhui reported that on May 31st, 2024, Abterra Medical (301097.SZ) held the 14th Board of Directors and passed the proposal on joint investment and related transactions with affiliated parties. It agreed to increase the capital by RMB 60 million to Ningbo Tianhuiyi Enterprise Management Co., Ltd. (referred to as "Ningbo Tianhuiyi" or "SPVB"). After the capital increase, Abterra Medical will hold 20.87% equity of Ningbo Tianhuiyi.
天益医疗(301097.SZ)：拟向宁波天辉益增资6000万元
Tianyi Medical (301097.SZ): Plans to increase capital by 60 million yuan to Ningbo Tianhuiyi
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.